Fast Track Initiative — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
LUCA Scienceluca-science.comJun 2022
LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction.
BiotechDeep TechHealthtechLongevity
Co-investorsRemiges Ventures, Inc.4BIO CapitalDCI Partners Co. Ltd.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.